-->

Company Registry

ZelosDx (AKA:MSDx Inc)
Profile last edited on: 3/23/2022

Neurodegenerative disease detection: blood testting products
Year Founded
2010
First SBIR Year
2021
Latest SBIR Award
2021
Program Status
Active

WikiProfile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

245 South Plumer Avenue Unit 7
Tucson, AZ 85719
   (520) 369-2143
   N/A
   www.zelosdx.com
Multiple Locations:   
Congressional District:   02
County:   Pima

Public Profile

ZelosDx. - previously dba MSDx, Inc. - is structured around development of blood testing products that are designed to enable researchers to make breakthrough discoveries in brain health and disease. Principals of the firm are developing blood test(s) to predict which patients may develop neurodegenerative diseases like #Alzheimers. By coupling TMS research at the University of Arizona with biomarker tech from bioindustry, it is the judgment of management that a more holistic view could be achieved re. how the brain changes along the spectrum from healthy to cognitive decline.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
---
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount Project Title
2021 1 NSF $255,763
Phagocytic Cells in Peripheral Blood as a Novel Diagnostic Tool for Brain Health

Key People / Management

  Marie Wesselhoft -- President and Co-Founder

  Ying-Hui Chou --

  Uwe Muller --

  Vanessa White -- formerly Research Associate

SBIR firms in the news

There are no news available.